Back to search
Asymptomatic COVID-19 Infection Laboratory-Confirmed
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Asymptomatic COVID-19 Infection Laboratory-Confirmed trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Asymptomatic COVID-19 Infection Laboratory-Confirmed trials you may qualify forPlasma from patients who have recovered from coronavirus disease 2019 (COVID-19) is referred to as COVID-19 convalescent plasma (CCP), and may contain antibodie…
This phase II trial studies the effects of ibrutinib in treating patients with B-cell malignancies who are infected with COVID-19. Ibrutinib may stop the growth…